Non-receptor-mediated actions are responsible for the lipid-lowering effects of iodothyronines in FaO rat hepatoma cells

Journal of Endocrinology

Volumn 210, Issue 1, 2011, Pages 59-69

  Grasselli, Elena ^a   Voci, Adriana ^a   Canesi, Laura ^a,c   Goglia, Fernando ^b   Ravera, Silvia ^a   Panfoli, Isabella ^a   Gallo, Gabriella ^a   Vergani, Laura ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF SANNIO   (Italy)

^c NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A OXIDASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IODOTHYRONINE; LIOTHYRONINE; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA; TRIACYLGLYCEROL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FATTY LIVER; GENE EXPRESSION; HEPATOMA CELL; IN VITRO STUDY; LIPID STORAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALDEHYDE OXIDASE; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DIIODOTHYRONINES; FATTY LIVER; GENE EXPRESSION REGULATION; HEPATOCYTES; HYPOLIPIDEMIC AGENTS; LIVER NEOPLASMS; PPAR DELTA; PPAR GAMMA; RATS; RECEPTORS, THYROID HORMONE; RNA, MESSENGER; STEAROYL-COA DESATURASE; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONE RECEPTORS BETA; TRIIODOTHYRONINE, REVERSE; UNCOUPLING AGENTS;

EID: 79960315827     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-11-0074     Document Type: Article

References (72)

1. Arnold S, Goglia F & Kadenbach B. 1998 3,5-Diiodothyronine binds to subunit Va of cytochrome-c oxidase and abolishes the allosteric inhibition of respiration by ATP. European Journal of Biochemistry 252 325-330.
2. 2) has selective thyromimetic effects in vivo and in vitro. Journal of Molecular Endocrinology 19 137-147.
3. Barish GD, Narkar VA & Evans RM. 2006 PPAR delta: a dagger in the heart of the metabolic syndrome. Journal of Clinical Investigation 116 590-597.
4. Bassett JH, Harvey CB & Williams GR. 2003 Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Molecular and Cellular Endocrinology 213 1-11.
5. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S & Davis PJ. 2005 Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146 2864-2871.
6. Burns KA & Vanden Heuvel JP. 2007 Modulation of PPAR activity via phosphorylation. Biochimica et Biophysica Acta 1771 952-960.
7. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, PfafflMW, Shipley GL et al. 2009 TheMIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry 55 611-622.
8. Casas F, Pessemesse L, Grandemange S, Seyer P, Baris O, Gueguen N, Ramonatxo C, Perrin F, Fouret G, Lepourry L et al. 2009 Overexpression of the mitochondrial T3 receptor induces skeletal muscle atrophy during aging. PLoS ONE 4 e5631.
9. Cheng SY, Leonard JL & Davis PJ. 2010 Molecular aspects of thyroid hormone actions. Endocrine Reviews 31 139-170.
10. Chomczynski P & Sacchi N. 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 156-159.
11. Chu R, Lin Y, Rao MS & Reddy JK. 1995 Cooperative formation of higher order peroxisome proliferator-activated receptor and retinoid X receptor complexes on the peroxisome proliferator responsive element of the rat hydratase-dehydrogenase gene. Journal of Biological Chemistry 270 29636-29639.
12. Cimmino M, Mion F, Goglia F, Minaire Y & Geloen A. 1996 Demonstration of in vivo metabolic effects of 3,5-di-iodothyronine. Journal of Endocrinology 149 319-325.
13. Cioffi F, Lanni A & Goglia F;. 2010a Thyroid hormones, mitochondrial bioenergetics and lipid handling. Current Opinion in Endocrinology, Diabetes, and Obesity 17 402-407.
14. Cioffi F, Zambad SP, Chhipa L, Senese R, Busiello RA, Tuli D, Munshi S, Moreno M, Lombardi A, Gupta RC et al. 2010b TRC150094, a novel functional analog of iodothyronines, reduces adiposity by increasing energy expenditure and fatty acid oxidation in rats receiving a high-fat diet. FASEB Journal 24 3451-3461.
15. Clayton DF, WeissM& Darnell JE Jr. 1985 Liver-specific RNA metabolism in hepatoma cells: variations in transcription rates and mRNA levels. Molecular and Cellular Biology 5 2633-2641.
16. Cocco T, Pacelli C, Sgobbo P & Villani G. 2009 Control of OXPHOS efficiency by complex I in brain mitochondria. Neurobiology of Aging 30 622-629.
17. Davis P;. 2010 New insights into thyroid hormone actions and lipid metabolism. Current Opinion in Endocrinology, Diabetes, and Obesity 17 395.
18. Davis PJ, Leonard JL & Davis FB. 2008 Mechanisms of nongenomic actions of thyroid hormone. Frontiers in Neuroendocrinology 29 211-218.
19. Demori I, Bottazzi C, Voci A, Gallo G, Scharf JG & Fugassa E. 1997 Triiodothyronine increases insulin-like growth factor binding protein-4 expression in rat hepatocytes. Journal of Endocrinology 154 155-165.
20. Demori I, Gerdoni E, Fugassa E & Voci A. 2004 3,5-Diiodothyronine mimics the effect of triiodothyronine on insulin-like growth factor binding protein-4 expression in cultured rat hepatocytes. Hormone and Metabolic Research 36 679-685.
21. Fava G, Ueno Y, Glaser S, Francis H, Demorrow S, Marucci L, Marzioni M, Benedetti A, Venter J, Vaculin B et al. 2007 Thyroid hormone inhibits biliary growth in bile duct-ligated rats by PLC/IP(3)/Ca(2C)-dependent downregulation of SRC/ERK1/2. American Journal of Physiology. Cell Physiology 292 C1467-C1475.
22. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ & Gores GJ. 2004 Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40 185-194.
23. Ferrannini E, Barrett EJ, Bevilacqua S & DeFronzo RA. 1983 Effect of fatty acids on glucose production and utilization in man. Journal of Clinical Investigation 72 1737-1747.
24. Flores-Morales A, Gullberg H, Fernandez L, Stahlberg N, Lee NH, Vennstrom B & Norstedt G. 2002 Patterns of liver gene expression governed by TRbeta. Molecular Endocrinology 16 1257-1268.
25. Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ & Reitman ML. 2003 Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. Journal of Biological Chemistry 278 34268-34276.
26. Giudetti AM, Leo M, Geelen MJ & Gnoni GV. 2005 Short-term stimulation of lipogenesis by 3,5-L-diiodothyronine in cultured rat hepatocytes. Endocrinology 146 3959-3966.
27. Goglia F, Lanni A, Barth J & Kadenbach B. 1994 Interaction of diiodothyronines with isolated cytochrome c oxidase. FEBS Letters 346 295-298.
28. Goglia F, Moreno M & Lanni A. 1999 Action of thyroid hormones at the cellular level: the mitochondrial target. FEBS Letters 452 115-120.
29. Grasselli E, Canesi L, Voci A, De Matteis R, Demori I, Fugassa E & Vergani L. 2008 Effects of 3,5-diiodo-L-thyronine administration on the liver of high fat diet-fed rats. Experimental Biology and Medicine 233 549-557.
30. Grasselli E, Voci A, Pesce C, Canesi L, Fugassa E, Gallo G & Vergani L. 2010 PAT protein mRNA expression in primary rat hepatocytes: effects of exposure to fatty acids. International Journal of Molecular Medicine 25 505-512.
31. Grasselli E, Voci A, Canesi L, De Matteis R, Goglia F, Cioffi F, Fugassa E, Gallo G & Vergani L;. 2011 Direct effects of iodothyronines on excess fat storage in rat hepatocytes. Journal of Hepatology. In press
32. Horst C, Rokos H & Seitz HJ. 1989 Rapid stimulation of hepatic oxygen consumption by 3,5-di-iodo-L-thyronine. Biochemical Journal 261 945-950.
33. Izumo S & Mahdavi V. 1988 Thyroid hormone receptor alpha isoforms generated by alternative splicing differentially activate myosin HC gene transcription. Nature 334 539-542.
34. Konig B & Eder K. 2006 Differential action of 13-HPODE on PPARalpha downstream genes in rat Fao and human HepG2 hepatoma cell lines. Journal of Nutritional Biochemistry 17 410-418.
35. Konig B, Koch A, Giggel K, Dordschbal B, Eder K & Stangl GI. 2008 Monocarboxylate transporter (MCT)-1 is up-regulated by PPARalpha. Biochimica et Biophysica Acta 1780 899-904.
36. Koopman R, Schaart G & Hesselink MK. 2001 Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochemistry and Cell Biology 116 63-68.
37. Lanni A, Moreno M, Lombardi A, de Lange P, Silvestri E, Ragni M, Farina P, Baccari GC, Fallahi P, Antonelli A et al. 2005 3,5-Diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats. FASEB Journal 19 1552-1554.
38. Lauris V, Crettaz M & Kahn CR. 1986 Coordinate roles of insulin and glucose on the growth of hepatoma cells in culture. Endocrinology 118 2519-2524.
39. Lazar MA. 1993 Thyroid hormone receptors: multiple forms, multiple possibilities. Endocrine Reviews 14 184-193.
40. Lu C & Cheng S.Y. 2010 Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferatoractivated receptors. Journal of Molecular Endocrinology 44 143-154.
41. Martin G, Schoonjans K, Lefebvre AM, Staels B & Auwerx J. 1997 Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. Journal of Biological Chemistry 272 28210-28217.
42. Mollica MP, Lionetti L, Moreno M, Lombardi A, De Lange P, Antonelli A, Lanni A, Cavaliere G, Barletta A & Goglia F. 2009 3,5-Diiodo-L-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet. Journal of Hepatology 51 363-370.
43. Moreno M, Lanni A, Lombardi A & Goglia F. 1997 How the thyroid controls metabolismin the rat: different roles for triiodothyronine and diiodothyronines. Journal of Physiology 2 529-538.
44. 3 itself? Endocrinology 143 504-510.
45. Moreno M, Lombardi A, Silvestri E, Senese R, Cioffi F, Goglia F, Lanni A & de Lange P;. 2010 PARs: nuclear receptors controlled by, and controlling, nutrient handling through nuclear and cytosolic signaling. PPAR Research;. 2010, Article ID 435689.
46. Munoz A, Hoppner W, Sap J, Brady G, Nordstrom K, Seitz HJ & Vennstrom B. 1990 The chicken c-erbA alpha-product induces expression of thyroid hormone-responsive genes in 3,5,30-triiodothyronine receptor-deficient rat hepatoma cells. Molecular Endocrinology 4 312-320.
47. NagasawaT, InadaY, Nakano S, TamuraT, TakahashiT, MaruyamaK, Yamazaki Y, Kuroda J & Shibata N. 2006 Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet. European Journal of Pharmacology 536 182-191.
48. Nobes CD, Brown GC, Olive PN & Brand MD. 1990 Non-ohmic proton conductance of the mitochondrial inner membrane in hepatocytes. Journal of Biological Chemistry 265 12903-12909.
49. Pfaff lMW 2001 A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Research 29 e45.
50. Qin B, Anderson RA & Adeli K. 2008 Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling. American Journal of Physiology. Gastrointestinal and Liver Physiology 294 G1120-G1129.
51. Ramzan R, Staniek K, Kadenbach B & Vogt S. 2010 Mitochondrial respiration and membrane potential are regulated by the allosteric ATP-inhibition of cytochrome c oxidase. Biochimica et Biophysica Acta 1797 1672-1680.
52. Ravera S, Panfoli I, Calzia D, AluigiMG, Bianchini P, Diaspro A, Mancardi G & Morelli A. 2009 Evidence for aerobic ATP synthesis in isolated myelin vesicles. International Journal of Biochemistry and Cell Biology 41 1581-1591.
53. Ricchi M, Odoardi MR, Carulli L, Anzivino C, Ballestri S, Pinetti A, Fantoni LI, Marra F, Bertolotti M, Banni S et al. 2009 Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. Journal of Gastroenterology and Hepatology 24 830-840.
54. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW & Griffin JL. 2009 Increased hepatic oxidative metabolism distinguishes the action of peroxisome proliferator-activated receptor delta from peroxisome proliferator-activated receptor gamma in the ob/ob mouse. Genome Medicine 1 115.
55. Rooda SJ, van Loon MA & Visser TJ. 1987 Metabolism of reverse triiodothyronine by isolated rat hepatocytes. Journal of Clinical Investigation 79 1740-1748.
56. Schadinger SE, Bucher NL, Schreiber BM & Farmer SR. 2005 PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. American Journal of Physiology. Endocrinology and Metabolism 288 E1195-E1205.
57. Schoonjans K, Staels B & Auwerx J. 1996 The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochimica et Biophysica Acta 1302 93-109.
58. Shan W, Nicol CJ, Ito S, Bility MT, Kennett MJ, Ward JM, Gonzalez FJ & Peters JM. 2008 Peroxisome proliferator-activated receptor-beta/delta protects against chemically induced liver toxicity in mice. Hepatology 47 225-235.
59. Sterling K & Brenner MA. 1995 Thyroid hormone action: effect of triiodothyronine on mitochondrial adenine nucleotide translocase in vivo and in vitro. Metabolism 44 193-199.
60. Sterling K, Campbell GA & Brenner MA. 1984 Purification of the mitochondrial triiodothyronine (T3) receptor from rat liver. Acta Endocrinologica 105 391-397.
61. Viswakarma N, Jia Y, Bai L, Vluggens A, Borensztajn J, Xu J & Reddy JK. 2010 Coactivators in PPAR-regulated gene expression. PPAR Research;. 2010, Article ID 250126.
62. Vock C, Gleissner M, Klapper M & Doring F. 2008 Oleate regulates genes controlled by signaling pathways of mitogen-activated protein kinase, insulin, and hypoxia. Nutrition Research 28 681-689.
63. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H & Evans RM. 2003 Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113 159-170.
64. Waters KM, Miller CW & Ntambi JM. 1997 Localization of a negative thyroid hormone-response region in hepatic stearoyl-CoA desaturase gene 1. Biochemical and Biophysical Research Communications 233 838-843.
65. Weiss RE, Murata Y, Cua K, Hayashi Y, Seo H & Refetoff S. 1998 Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor beta-deficient mice. Endocrinology 139 4945-4952.
66. Wiechelman KJ, Braun RD & Fitzpatrick JD. 1988 Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for color formation. Analytical Biochemistry 175 231-237.
67. Wrutniak C, Cassar-Malek I, Marchal S, Rascle A, Heusser S, Keller JM, Flechon J, Dauca M, Samarut J, Ghysdael J et al. 1995 A 43-kDa protein related to c-Erb A alpha 1 is located in the mitochondrial matrix of rat liver. Journal of Biological Chemistry 270 16347-16354.
68. Wrutniak-Cabello C, Casas F & Cabello G. 2001 Thyroid hormone action in mitochondria. Journal of Molecular Endocrinology 26 67-77.
69. Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, Willson TM et al. 1999 Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Molecular Cell 3 397-403.
70. Yao-Borengasser A, Rassouli N, Varma V, Bodles AM, Rasouli N, Unal R, Phanavanh B, Ranganathan G, McGehee RE Jr & Kern PA. 2008 Stearoylcoenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness. Journal of Clinical Endocrinology 93 4431-4439.
71. Ye L, Li YL, Mellstrom K, Mellin C, Bladh LG, Koehler K, Garg N, Garcia Collazo AM, Litten C, Husman B et al. 2003 Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1. Journal of Medicinal Chemistry 46 1580-1588.
72. Yu S, Matsusue JK, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, RaoMS, Gonzalez FJ & Reddy JK. 2003 Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferatoractivated receptor gamma1 (PPARgamma1) overexpression. Journal of Biological Chemistry 278 498-505.